Literature DB >> 16426809

Expression of OmpP2A and OmpP2B is not required for pustule formation by Haemophilus ducreyi in human volunteers.

Diane Janowicz1, Nicole R Luke, Kate R Fortney, Barry P Katz, Anthony A Campagnari, Stanley M Spinola.   

Abstract

Haemophilus ducreyi express two porin proteins, termed OmpP2A and OmpP2B. To test whether expression of OmpP2A and OmpP2B was necessary for virulence in humans, eight volunteers were experimentally infected with the parent (35000HP) in one arm and a double OmpP2A OmpP2B mutant (35000HP::P2AB) in the other arm. The pustule formation rates were 58.3% (95% CI, 33.2-83.5%) for the parent and 41.7% (95% CI, 19.3-64.0%) for the mutant (P=0.25). Biopsy of 35000HP and 35000HP::P2AB-infected sites yielded similar amounts of bacteria in quantitative culture. These results indicate that expression of OmpP2A and OmpP2B is not necessary to initiate disease or to progress to pustule formation in humans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16426809     DOI: 10.1016/j.micpath.2005.11.005

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  11 in total

1.  Experimental infection with Haemophilus ducreyi in persons who are infected with HIV does not cause local or augment systemic viral replication.

Authors:  Diane M Janowicz; Klara Tenner-Racz; Paul Racz; Tricia L Humphreys; Carol Schnizlein-Bick; Kate R Fortney; Beth Zwickl; Barry P Katz; James J Campbell; David D Ho; Stanley M Spinola
Journal:  J Infect Dis       Date:  2007-04-05       Impact factor: 5.226

2.  Regulation of expression of the Haemophilus ducreyi LspB and LspA2 proteins by CpxR.

Authors:  Maria Labandeira-Rey; Jason R Mock; Eric J Hansen
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

3.  Comparative proteomic analysis of the Haemophilus ducreyi porin-deficient mutant 35000HP::P2AB.

Authors:  Jeremiah J Davie; Anthony A Campagnari
Journal:  J Bacteriol       Date:  2008-12-19       Impact factor: 3.490

4.  Role played by CD4+FOXP3+ regulatory T Cells in suppression of host responses to Haemophilus ducreyi during experimental infection of human volunteers.

Authors:  Wei Li; Klara Tenner-Racz; Paul Racz; Diane M Janowicz; Kate R Fortney; Barry P Katz; Stanley M Spinola
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

5.  Haemophilus ducreyi partially activates human myeloid dendritic cells.

Authors:  Keith E Banks; Tricia L Humphreys; Wei Li; Barry P Katz; David S Wilkes; Stanley M Spinola
Journal:  Infect Immun       Date:  2007-10-08       Impact factor: 3.441

6.  Experimental infection of human volunteers with Haemophilus ducreyi: fifteen years of clinical data and experience.

Authors:  Diane M Janowicz; Susan Ofner; Barry P Katz; Stanley M Spinola
Journal:  J Infect Dis       Date:  2009-06-01       Impact factor: 5.226

7.  Identification of Haemophilus ducreyi genes expressed during human infection.

Authors:  Margaret E Bauer; Kate R Fortney; Alistair Harrison; Diane M Janowicz; Robert S Munson; Stanley M Spinola
Journal:  Microbiology       Date:  2008-04       Impact factor: 2.777

8.  A (p)ppGpp-null mutant of Haemophilus ducreyi is partially attenuated in humans due to multiple conflicting phenotypes.

Authors:  Concerta Holley; Dharanesh Gangaiah; Wei Li; Kate R Fortney; Diane M Janowicz; Sheila Ellinger; Beth Zwickl; Barry P Katz; Stanley M Spinola
Journal:  Infect Immun       Date:  2014-06-09       Impact factor: 3.441

9.  Activation of CpxRA in Haemophilus ducreyi primarily inhibits the expression of its targets, including major virulence determinants.

Authors:  Dharanesh Gangaiah; Xinjun Zhang; Kate R Fortney; Beth Baker; Yunlong Liu; Robert S Munson; Stanley M Spinola
Journal:  J Bacteriol       Date:  2013-05-31       Impact factor: 3.490

10.  Inactivation of the Haemophilus ducreyi luxS gene affects the virulence of this pathogen in human subjects.

Authors:  Maria Labandeira-Rey; Diane M Janowicz; Robert J Blick; Kate R Fortney; Beth Zwickl; Barry P Katz; Stanley M Spinola; Eric J Hansen
Journal:  J Infect Dis       Date:  2009-08-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.